CI
The startup develops cell therapies and small molecule therapeutics that utilize the body's innate healing mechanisms to treat cancer, autoimmune diseases, chronic inflammation, and metabolic disorders. By enhancing the self-healing process, the company aims to improve patient outcomes in managing these chronic illnesses.
Updated 3 months ago
Funding
$9M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops cell therapies and small molecule therapeutics that utilize the body's innate healing mechanisms to treat cancer, autoimmune diseases, chronic inflammation, and metabolic disorders. By enhancing the self-healing process, the company aims to improve patient outcomes in managing these chronic illnesses.